Cargando…

The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis

BACKGROUND: Ovarian cancer (OCa) peritoneal metastasis is the leading cause of cancer–related deaths in women with limited therapeutic options available for treating it and poor prognosis, as the underlying mechanism is not fully understood. METHOD: The clinicopathological correlation of G9a express...

Descripción completa

Detalles Bibliográficos
Autores principales: Hua, Kuo-Tai, Wang, Ming-Yang, Chen, Min-Wei, Wei, Lin-Hung, Chen, Chi-Kuan, Ko, Ching-Huai, Jeng, Yung-Ming, Sung, Pi-Lin, Jan, Yi-Hua, Hsiao, Michael, Kuo, Min-Liang, Yen, Men-Luh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260797/
https://www.ncbi.nlm.nih.gov/pubmed/25115793
http://dx.doi.org/10.1186/1476-4598-13-189
_version_ 1782348227131998208
author Hua, Kuo-Tai
Wang, Ming-Yang
Chen, Min-Wei
Wei, Lin-Hung
Chen, Chi-Kuan
Ko, Ching-Huai
Jeng, Yung-Ming
Sung, Pi-Lin
Jan, Yi-Hua
Hsiao, Michael
Kuo, Min-Liang
Yen, Men-Luh
author_facet Hua, Kuo-Tai
Wang, Ming-Yang
Chen, Min-Wei
Wei, Lin-Hung
Chen, Chi-Kuan
Ko, Ching-Huai
Jeng, Yung-Ming
Sung, Pi-Lin
Jan, Yi-Hua
Hsiao, Michael
Kuo, Min-Liang
Yen, Men-Luh
author_sort Hua, Kuo-Tai
collection PubMed
description BACKGROUND: Ovarian cancer (OCa) peritoneal metastasis is the leading cause of cancer–related deaths in women with limited therapeutic options available for treating it and poor prognosis, as the underlying mechanism is not fully understood. METHOD: The clinicopathological correlation of G9a expression was assessed in tumor specimens of ovarian cancer patients. Knockdown or overexpression of G9a in ovarian cancer cell lines was analysed with regard to its effect on adhesion, migration, invasion and anoikis-resistance. In vivo biological functions of G9a were tested by i.p. xenograft ovarian cancer models. Microarray and quantitative RT-PCR were used to analyze G9a-regulated downstream target genes. RESULTS: We found that the expression of histone methyltransferase G9a was highly correlated with late stage, high grade, and serous-type OCa. Higher G9a expression predicted a shorter survival in ovarian cancer patients. Furthermore, G9a expression was higher in metastatic lesions compared with their corresponding ovarian primary tumors. Knockdown of G9a expression suppressed prometastatic cellular activities including adhesion, migration, invasion and anoikis-resistance of ovarian cancer cell lines, while G9a over-expression promoted these cellular properties. G9a depletion significantly attenuated the development of ascites and tumor nodules in a peritoneal dissemination model. Importantly, microarray and quantitative RT-PCR analysis revealed that G9a regulates a cohort of tumor suppressor genes including CDH1, DUSP5, SPRY4, and PPP1R15A in ovarian cancer. Expression of these genes was also inversely correlated with G9a expression in OCa specimens. CONCLUSION: We propose that G9a contributes to multiple steps of ovarian cancer metastasis and represents a novel target to combat this deadly disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1476-4598-13-189) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4260797
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42607972014-12-10 The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis Hua, Kuo-Tai Wang, Ming-Yang Chen, Min-Wei Wei, Lin-Hung Chen, Chi-Kuan Ko, Ching-Huai Jeng, Yung-Ming Sung, Pi-Lin Jan, Yi-Hua Hsiao, Michael Kuo, Min-Liang Yen, Men-Luh Mol Cancer Research BACKGROUND: Ovarian cancer (OCa) peritoneal metastasis is the leading cause of cancer–related deaths in women with limited therapeutic options available for treating it and poor prognosis, as the underlying mechanism is not fully understood. METHOD: The clinicopathological correlation of G9a expression was assessed in tumor specimens of ovarian cancer patients. Knockdown or overexpression of G9a in ovarian cancer cell lines was analysed with regard to its effect on adhesion, migration, invasion and anoikis-resistance. In vivo biological functions of G9a were tested by i.p. xenograft ovarian cancer models. Microarray and quantitative RT-PCR were used to analyze G9a-regulated downstream target genes. RESULTS: We found that the expression of histone methyltransferase G9a was highly correlated with late stage, high grade, and serous-type OCa. Higher G9a expression predicted a shorter survival in ovarian cancer patients. Furthermore, G9a expression was higher in metastatic lesions compared with their corresponding ovarian primary tumors. Knockdown of G9a expression suppressed prometastatic cellular activities including adhesion, migration, invasion and anoikis-resistance of ovarian cancer cell lines, while G9a over-expression promoted these cellular properties. G9a depletion significantly attenuated the development of ascites and tumor nodules in a peritoneal dissemination model. Importantly, microarray and quantitative RT-PCR analysis revealed that G9a regulates a cohort of tumor suppressor genes including CDH1, DUSP5, SPRY4, and PPP1R15A in ovarian cancer. Expression of these genes was also inversely correlated with G9a expression in OCa specimens. CONCLUSION: We propose that G9a contributes to multiple steps of ovarian cancer metastasis and represents a novel target to combat this deadly disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1476-4598-13-189) contains supplementary material, which is available to authorized users. BioMed Central 2014-08-12 /pmc/articles/PMC4260797/ /pubmed/25115793 http://dx.doi.org/10.1186/1476-4598-13-189 Text en © Hua et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Hua, Kuo-Tai
Wang, Ming-Yang
Chen, Min-Wei
Wei, Lin-Hung
Chen, Chi-Kuan
Ko, Ching-Huai
Jeng, Yung-Ming
Sung, Pi-Lin
Jan, Yi-Hua
Hsiao, Michael
Kuo, Min-Liang
Yen, Men-Luh
The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis
title The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis
title_full The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis
title_fullStr The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis
title_full_unstemmed The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis
title_short The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis
title_sort h3k9 methyltransferase g9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260797/
https://www.ncbi.nlm.nih.gov/pubmed/25115793
http://dx.doi.org/10.1186/1476-4598-13-189
work_keys_str_mv AT huakuotai theh3k9methyltransferaseg9aisamarkerofaggressiveovariancancerthatpromotesperitonealmetastasis
AT wangmingyang theh3k9methyltransferaseg9aisamarkerofaggressiveovariancancerthatpromotesperitonealmetastasis
AT chenminwei theh3k9methyltransferaseg9aisamarkerofaggressiveovariancancerthatpromotesperitonealmetastasis
AT weilinhung theh3k9methyltransferaseg9aisamarkerofaggressiveovariancancerthatpromotesperitonealmetastasis
AT chenchikuan theh3k9methyltransferaseg9aisamarkerofaggressiveovariancancerthatpromotesperitonealmetastasis
AT kochinghuai theh3k9methyltransferaseg9aisamarkerofaggressiveovariancancerthatpromotesperitonealmetastasis
AT jengyungming theh3k9methyltransferaseg9aisamarkerofaggressiveovariancancerthatpromotesperitonealmetastasis
AT sungpilin theh3k9methyltransferaseg9aisamarkerofaggressiveovariancancerthatpromotesperitonealmetastasis
AT janyihua theh3k9methyltransferaseg9aisamarkerofaggressiveovariancancerthatpromotesperitonealmetastasis
AT hsiaomichael theh3k9methyltransferaseg9aisamarkerofaggressiveovariancancerthatpromotesperitonealmetastasis
AT kuominliang theh3k9methyltransferaseg9aisamarkerofaggressiveovariancancerthatpromotesperitonealmetastasis
AT yenmenluh theh3k9methyltransferaseg9aisamarkerofaggressiveovariancancerthatpromotesperitonealmetastasis
AT huakuotai h3k9methyltransferaseg9aisamarkerofaggressiveovariancancerthatpromotesperitonealmetastasis
AT wangmingyang h3k9methyltransferaseg9aisamarkerofaggressiveovariancancerthatpromotesperitonealmetastasis
AT chenminwei h3k9methyltransferaseg9aisamarkerofaggressiveovariancancerthatpromotesperitonealmetastasis
AT weilinhung h3k9methyltransferaseg9aisamarkerofaggressiveovariancancerthatpromotesperitonealmetastasis
AT chenchikuan h3k9methyltransferaseg9aisamarkerofaggressiveovariancancerthatpromotesperitonealmetastasis
AT kochinghuai h3k9methyltransferaseg9aisamarkerofaggressiveovariancancerthatpromotesperitonealmetastasis
AT jengyungming h3k9methyltransferaseg9aisamarkerofaggressiveovariancancerthatpromotesperitonealmetastasis
AT sungpilin h3k9methyltransferaseg9aisamarkerofaggressiveovariancancerthatpromotesperitonealmetastasis
AT janyihua h3k9methyltransferaseg9aisamarkerofaggressiveovariancancerthatpromotesperitonealmetastasis
AT hsiaomichael h3k9methyltransferaseg9aisamarkerofaggressiveovariancancerthatpromotesperitonealmetastasis
AT kuominliang h3k9methyltransferaseg9aisamarkerofaggressiveovariancancerthatpromotesperitonealmetastasis
AT yenmenluh h3k9methyltransferaseg9aisamarkerofaggressiveovariancancerthatpromotesperitonealmetastasis